Company Filing History:
1 out of 11 
1 out of 5,111 
Years Active: 2012
Title: The Innovations of Stephane Duvezin-Caubet
Introduction
Stephane Duvezin-Caubet is an accomplished inventor based in Mimbaste, France. He has made significant contributions to the field of biotechnology, particularly in the study of mitochondrial pathologies. His work focuses on developing innovative solutions to combat diseases related to ATP production deficiencies.
Latest Patents
Duvezin-Caubet holds a patent for modified yeast cells that include mutations in the mitochondrial ATP6 gene. This patent addresses NARP syndrome in humans and provides a method for screening medicaments that target mitochondrial pathologies. His innovative approach has the potential to lead to new treatments for conditions involving oxidative phosphorylation deficiencies.
Career Highlights
Throughout his career, Duvezin-Caubet has been associated with prestigious institutions such as Université Victor Segalen—Bordeaux 2 and the Centre National de la Recherche Scientifique. His work at these organizations has allowed him to advance his research and collaborate with other experts in the field.
Collaborations
Duvezin-Caubet has worked alongside notable colleagues, including Jean-Paul Di Rago and Malgorzata Rak. These collaborations have enriched his research and contributed to the development of innovative solutions in biotechnology.
Conclusion
Stephane Duvezin-Caubet's contributions to the field of biotechnology, particularly through his patent addressing mitochondrial pathologies, highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.